期刊文献+

原发性醛固酮增多症患者左室肥厚和颈动脉硬化的发生及相关性 被引量:7

Left ventricular hypertrophy and carotid atherosclerosis in patients with primary aldosteronism
下载PDF
导出
摘要 目的探讨原发性醛固酮增多症(PA)患者左室肥厚和颈动脉粥样硬化的情况。方法选取确诊的PA患者32例(PA组,腺瘤22例、增生10例),同期另择原发性高血压患者20例作为对照组,分别测定其生化指标、血醛固酮(ALD)浓度、血浆。肾素活性(PRA);并行颈动脉B超及心超检查,测定颈动脉内膜中层厚度(IMT)及左室肥厚情况。结果(1)两组患者仅K^+、LVMt、IMT差异明显(P〈0.05),其他指标均无明显差异(P〉005)。PA组发生左室肥厚22例(68.75%);形成颈动脉斑块10例(31.25%)。对照组发生左室肥厚8例(40.00%);形成颈动脉斑块3例(15.00%)。PA组左室肥厚发生率明显高于对照组(P〈0.05),颈动脉斑块发生率较之对照组无明显差异(P〉0.05)。(2)PA组中两类患者各指标的差异均无统计学意义(P〉0.05)。腺瘤患者发生左室肥厚16例(72.73%);形成颈动脉斑块6例(27.23%)。对照组发生左室肥厚6例(60.00%);形成颈动脉斑块4例(40.00%)。两类患者左室肥厚和颈动脉斑块发生率均无明显差异(均P〉0.05)。(3)PA患者中,剔除病程、收缩压、Cr的影响,LVMI与卧位及立位ALD浓度均呈正相关(均P〈0.05);控制病程、年龄、收缩压、血糖、甘油三脂、总胆固醇等危险因素,IMT与卧位及立位ALD浓度均显著相关(均P〈0.05)。结论PA患者LVMI高于EH患者,左室肥厚发生率增加,颈动脉粥样硬化程度较EH患者严重。 Objective To evaluate left ventricular hypertrophy (LVH) and carotid atherosclerosis in patients with primary aldosteronism (PA). Methods Thirty two patients with PA, including 22 cases of adenomas (APA) and 10 cases of idiopathic hyperaldosteronism (IHA), were included in this study. Clinical characteristics, left ventricular mass index (LVMI) and carotidartery intima-mean thickness (iMT) were assessed in 32 PA patients and 20 matched controls with essential hypertension (EHT). Results There were no differences in plasma basic glucose, creatinine, triglycerides, total cholesterol and high-density lipoprotein between the groups. Plasma potassium was lower (2.87 ± 0.65 vs. 4.12 ± 0.44 mmol/l; P 〈 0.01) in PA patients. Patients with PA had higher LVMI (122.99 ± 16.53 vs. 114.29 ± 12.55 g/m^2; P 〈 0.05) and LVH was more frequent in those patients (P 〈 0.05). Carotid IMT was significant greater in FA patients than in EHT patients (1.15 ± 0.20 vs. 1.03 ± 0.19 mm; P 〈 0.05). By multivariate analysis, the concentrations of basic and upright plasma aldosterone independently predicted LVMI and carotid IMT after adjustment for all potential confounders. There were no differences in LVMI and IMT between APA patients and IHA patients. Conclusion The results suggest that the prevalence of LVH is higher and carotid atherosclerosis is more serious in PA patients. The concentration of plasma aldosterone is strongly associated with LVH and early carotid atherosclerosis among PA patients.
出处 《浙江医学》 CAS 2010年第1期57-59,共3页 Zhejiang Medical Journal
关键词 原发性醛固酮增多症 左室肥厚 左室重量指数 颈动脉粥样硬化 颈动脉内膜中层厚度 Primary aldosteronism Left ventricular hypertrophy Left ventricular mass index Carotid atherosclerosis Carotid intima-media thickness
  • 相关文献

参考文献15

  • 1Toniate A, Bernante P, Rossi G P. The role of adrenal venous sampling in the surgical management of primary aldosteronism [J]. World J Surg, 2006, 30: 624-627.
  • 2Keidar S, Kaplan M, Pavlotaky E, et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin Ⅱ and aldosterone[J]. Circulation, 2004, 109: 2213- 2220.
  • 3Takai S, Jin D, Muramatsu M, et al. Eplerenone inhibits atherosclerosis in nonhuman primates[J]. Hypertension, 2005, 46:1135- 1139.
  • 4Matsumura K, Fujii K, Oniki H, et al. Role of adosterone in left ventricular hypertrophy in hypertension[J]. Am J Hypertens, 2006, 19: 13-18.
  • 5Ganguly A. Primary aldosteronism[J]. N Engl J Med, 1998, 339 (25): 1828-1834.
  • 6曾正陪.协和内分泌和代谢学[M].北京:科学出版社,1999.1184-1197.
  • 72003 European society of hypertension European society of cardiology guidelines for the management of arterial hypertension, Guidelines committee[J] J Hypertens, 2003, 21: 1011-1053.
  • 8洪维,龚艳春,初少莉,陈绍行,郭冀珍,朱鼎良.原发性醛固酮增多症患者与左心室肥厚[J].中华高血压杂志,2008,16(2):112-116. 被引量:11
  • 9Epstein M Aldosterone receptor blockade and the role of epelernone: evolving perspectives [J]. Nephroldial Transplant, 2003, 18: 1984-1992.
  • 10Rossi G P, Ganzaroli C, Cesari M, et al. Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high to normal rennin hypertension[J].Cardiovasc Res, 2003, 57: 2772-2783,.

二级参考文献14

  • 1陈绍行,杜月凌,张瑾,龚艳春,胡亚蓉,初少莉,何清波,宋艳艳,朱鼎良.在高血压患者中筛选原发性醛固酮增多症国人血浆醛固酮/肾素活性比值标准的探讨[J].中华心血管病杂志,2006,34(10):868-872. 被引量:48
  • 2[1]Toniate A,Bernante P,Rossi GP.The role of adrenal venous sampling in the surgical management of primary aldosteronism[J].World J Surg,2006,30:624-627.
  • 3[2]Levy D,Garrisin RJ,Savage DD,et al.Prognostic implications of echocardiographically determined left ventricular mass in the framingham study[J].N Engl J Med,1990,322:1561-1566.
  • 4[3]Yoshimoto T,Hirata Y.Aldosterone as a Cardiovascular risk hormone[J].Endocr J,2007,54:359-370.
  • 5[4]Matsumura K,Fujii K,Oniki H,et al.Role of adosterone in left ventricular hypertrophy in hypertension[J].Am J Hypertens,2006,19:13-18.
  • 6[6]2003 European society of hypertension European society of cardiology guidelines for the management of arterial hypertension.Guidelines committee[J].J Hypertens,2003,21:1011-1053.
  • 7[7]Stowasser M,Gordon RD,Gunasekera TG,et al.High rat of detection of primary aldosteronism,including surgically treatable forms,following non-selective's creening of hypertensive patients[J].J Hypertens,2003,21:2149-2157.
  • 8[8]Devereux RB,Alonso DR,Lutas EM,et al.Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings[J].Am J Cardiol,1986,57:450-457.
  • 9[9]Milliez P,Girerd X,Plouin PF,et al.Evidence of an increased rate of cardiovasular events in patients with primary aldosteronism[J].J Am Coll Cardiol,2005,45:1243-1248.
  • 10[10]Nakahara T,Takata Y,Hirayama Y,et al.Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type Ⅲ amino-terminal peptide[J].Circulation,2007,71:716-721.

共引文献11

同被引文献64

  • 1Anna Aronova,Thomas J Fahey Ⅲ,Rasa Zarnegar.Management of hypertension in primary aldosteronism[J].World Journal of Cardiology,2014,6(5):227-233. 被引量:11
  • 2杜昕,易宗春,戴闺柱.血管紧张素Ⅱ和醛固酮对心脏成纤维细胞Ⅲ型胶原mRNA表达的影响[J].中华老年心脑血管病杂志,2000,2(1):45-47. 被引量:6
  • 3Mulatero P,Stowasser M,Loh KC,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,incenters from five continents[J] .J Clin Endocrinol Metab,2012,89(3):1045-1050.
  • 4Rossi GP,Bemin G,Caliumi C,et al.A prospective study of the prevalence of primary aldosteroneism in 1 125 hypertensive patients[J] .J Am Coll Cardiol,2006,48(11):2293-2300.
  • 5Stowasser M.Update in primary aldosteronism[J] .J Clin Endocrinol Metab,2009,94(10):3623-3630.
  • 6Milliez P,Girerd X,Plouin PF,et al.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J] .J Am Coll Cardiol,2005,45(8):1243-1248.
  • 7Mulatero P,Milan A,Williams TA,et al.Mineralocorticoid receptor blockade in the protection of target organ damage[J] .Cardiovasc Hematol Agents Med Chem,2006,4(1):75-91.
  • 8Matsumura K,Fujii K,Oniki H,et al.Role of adosterone in left ventrieular hypertrophy in hypertension[J] .Am J Hypertens,2006,19(1):13-18.
  • 9Rossi GP,Bolognesi M,Rizzoni D,et al.Vasular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients[J] .Hypertension,2012,51(5):1366-1371.
  • 10Mulathero P,Stowasser M,Loh KC. Increased diagnosis of primary aldosteronism including surgically or correctable forms,in centers from five continents[J].Journal of Clinical Endocrinology and Metabolism,2004,(03):1045-1050.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部